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Platinum nanoparticles (PNPs) were synthesized by chemical reduction of potassium hexachloroplatinate (IV) with
trisodium citrate under vigorous stirring and addition of sodium dodecyl sulfate as stabilizer reagent. Reducing
agent was chosen depending on the oxidation reactions and potential values of the chemical materials used in the
experiment. The aim of this study is to investigate the effects of PNPs on the different cancer cell lines and
cytotoxicity study of this nanomaterial. The morphology of PNPs was investigated by scanning electron microscope
(XL30, Philips Electronics, Amsterdam, The Netherlands) with the ability to perform elemental analysis by EDX.
Malvern Zetasizer 3000 HSA (Malvern Instruments, Worcestershire, UK) was used to determine the distribution of
particle size and zeta potential of PNPs. The cytotoxicity property of the nanoparticles was evaluated by MTT assay
on MCF-7 and HepG-2 cell lines, and the cytotoxic concentration 50% values were determined for 24 h.
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In recent years, the interest in the synthesis and proper-
ties of metal nanoparticles has been increasing because
of their unique properties and promising applications as
catalysts, ferrofluids, and semiconductors [1,2]. Nano-
technology is the most promising field for generating
new applications in medicine. However, only few
nanoproducts are currently in use for medical purposes
[3]. The most prominent nanoproduct is PNPs. PNPs
are generally smaller than 100 nm and contain 20 to
15,000 platinum atoms. Nanoparticles are often in the
range 1 to 100 nm, and this is the size as that of human
proteins. Metal nanoparticles possess a very high
surface-to-volume ratio. In biology and biochemistry,
nanoparticles have attracted much attention. Especially,
PNPs with size in the range of 10 to 50 nm are most at-
tractive for practical reasons [2-6]. Cancer killed 7.9 mil-
lion people worldwide in 2007 [7]. Breast cancer is one
of the leading causes of women mortality worldwide.
Chemotherapy is the only option for treating the malig-
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reproduction in any medium, provided the origspan of the patient [8]. Successful chemotherapy of can-
cer depends on the delivery of sufficient concentrations
of an effective drug to tumor cells without causing in-
tolerable toxicity to the patient. Platinum-based drugs
are traditional cancer drugs used in chemotherapy to kill
cancer cells. Consequently, an effective synthetic tech-
nique is required to produce nanoparticles with con-
trolled shape and small size within a few Angström
standard deviations. The usual synthetic technique for
making such nanoparticles involves chemical or electro-
chemical reduction of metal ions in the presence of a
stabilizer such as linear polymers [9-11] and ligands
[12-16] which prevent the nanoparticles from aggrega-
tion and allow isolation of the nanoparticles. To control
the particle size and shape, various reductants, stabi-
lizers, solvents etc., have been utilized in nanoparticle
preparation. The control of particle size and morphology
has been extensively studied using different stabilizers
[17-20]. MCF-7 and HepG-2 cells are a suitable in vitro
model system for the study of polarized human hepato-
cytes. MCF-7 cells are useful for in vitro breast cancer
studies because the cell line has retained several ideal
characteristics particular to the mammary epithelium
[21]. These include the ability for MCF-7 cells to process
estrogen, in the form of estradiol, via estrogen receptorshis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
Figure 1 SEM image of the mean diameter of PNPs about 34
nm using SDS as stabilizer.




F (k) 0.15 1.40
Na (k) 0.41 3.11
K (k) 1.90 8.47
Pt (L) 97.53 87.02
Total 100.00 100.00
k and L refer to level energy of X-ray that reflected from the
nanoparticle surface.
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estrogen receptor positive control cell line [22]. Because
of their high degree of morphological and functional dif-
ferentiation in vitro, HepG-2 cells are a suitable model
to study the intracellular trafficking and dynamics of bile
canalicular and sinusoidal membrane proteins and lipids
in human hepatocytes in vitro. In this research, we want
to synthesize stable PNPs by use of K2PtCl6 and a weak
reductant agent such as trisodium citrate then evaluate




Potassium hexachloroplatinate (IV) and trisodium citrate
of analytical grade purity were used as starting materials
without further purification. Platinum nanoparticles were
obtained by chemical reduction of K2PtCl6 (approximately
%38Pt, Sigma-Aldrich, MO, USA) with trisodium citrate
(Sigma-Aldrich). All solutions of reacting materials were
prepared in distilled water. In typical experiment, 50 ml of
0.001 M K2PtCl6 was heated to boiling point. To this solu-
tion, 5 ml of 1% trisodium citrate was added drop by drop.
The solution was stirred by magnetic stirrer (RH-KT/C,
IKA, Selangor, Malaysia) during the experiment. The
temperature was controlled using a water bath (Ultratemp
FP35-HC, Julabo GmbH, Seelbach, Germany). The solu-
tion was heated until color change is evident (bright yel-
low to black). Then, it was removed from the heating
element and stirred until cooled to room temperature.
Platinum precipitate was separated by centrifuge (NF 615,
Nuve, Ankara, Turkey) at 3, 000 rpm for 5 min. The pre-
cipitate formed by the metallic nanoparticles was washed
several times [23] with deionized water and acetone, then
put in acetone as a suspension. Then, the acetone and
water in liquid phase was vaporized in an oven at 110°C.
Mechanism of reaction could be expressed as follows [5,6]:
4Pt2þ þ C6H5O7Na3 þ 4H2O→4Pt0 þ C6H5O7H3
þ 3Naþ þ 5Hþ þ 202
Characterization methods
Morphological analysis and the measurement of the
nanoparticle size were performed by scanning elec-
tron microscope (SEM). Malvern Zetasizer 3000 HSA
(Malvern Instruments Ltd., Worcestershire, UK) was
also used to determine the size and zeta potential of the
platinum nanoparticles. This instrument allows the
measurement of particle size distributions in the range
above 2 nm and can also be used to measure the distri-
bution of zeta potentials for dispersed particles in a simi-
lar size range. The zeta potential is determined by
measuring the electrophoretic particle velocity in anelectrical field. During the particle movement, the diffuse
layer is shorn off; hence, the particle obtains a charge
due to the loss of the counter ions in the diffuse layer.
This potential at the plane of shear is called the zeta po-
tential. As this electric potential approaches zero, parti-
cles tend to aggregate.
Cell line and cell culture
MCF-7 and HepG-2 cell lines were obtained from the Na-
tional Cell Bank of Iran. The cells were cultured in DMEM
containing 10% FBS, 2 mM glutamine, antibiotics (penicil-
lin G, 60 mg/l; streptomycin, 100 mg/l; amphotericin B,
50 μl/l) under a humid atmosphere (37°C, 5% CO2).
Determination of cell viability and CC50
The cytotoxicity effect of PNPs on MCF-7 and HepG-2
cells was determined by MTT (Sigma, USA) assay.
Briefly, l04 cells/well were treated with various concen-
trations of PNPs 0, 1, 2, and 4 mg/ml. After the 24-h in-
cubation, the cells were washed twice with phosphate
buffered saline (PBS), and MTT (0.5 mg/ml PBS) was
added to each well and incubated at 37°C for 3 h. The
formazan crystals that formed were dissolved by adding
Figure 2 EDX spectrum of PNPs (about 34 nm in diameter).
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read at 570 nm using a microplate scanning spectropho-
tometer (ELISA reader, Organon Teknika, Netherlands).
The toxicity level was calculated using the following for-
mula [24]:
Cytotoxicity % ¼ 1− Meanabsorbanceof toxicant
Meanabsorbanceof negativecontrol
 100
Viability % = 100 − Cytotoxicity %
The CC50 values of PNPs on MCF-7 and HepG-2 cells
at 24 h were determined. CC50 was determined by probit
analysis using the Pharm PCS (Pharmacologic Calculation
System) statistical package (Springer-Verlag, USA).
Statistical analysis
The results were expressed as mean ± SD. Statistical sig-
nificances of difference throughout this study were cal-
culated using a Student t test and by one-way variance
analysis.Figure 3 SEM images of PNPs synthesized by chemical reduction withResults and discussion
Synthesis and characterization of PNPs
The particle size of the PNPs was measured by SEM.
The average size of the particles is about 34 nm as
shown in Figure 1. This means that PNPs have typical
nanomaterial characteristics and can be efficiently taken
up by cells. The results observed with the SEM show
that the particles in PNPs are spheroid, their surface is
smooth, and they are dispersed evenly without adhesion.
SEM micrographs of the platinum particles were
obtained in 25°C. In addition to the SEM images, we
collected EDX spectra of the PNPs to evaluate their
elemental composition. Table 1 presents a representative
spectrum showing well-resolved peaks for both platinum
(Lα and Lβ at 9 and 11 keV, respectively) and potassium
(Kα at 3.5 keV) shown in Figure 2. The observed potas-
sium in the EDX spectra is due to the presence of a
small number of potassium from incomplete K2PtCl6.
We observed no peaks that were unambiguously attrib-
utable to PNPs, which were expected given the low
atomic numbers of the constituent elements. Chemical
reduction techniques have been extensively investigated
in the preparation of nanoparticles because these
methods can be implemented under simple and mild
conditions, and can be used to prepare nanoparticles on
a large scale. A weak reductant will result in slow reac-
tion for the formation of metal atoms, which may be fa-
vorable for the size and morphology control of the metal
nanoparticles obtained. Hence, we utilized a weak reduc-
tant, trisodium citrate, to synthesize the noble PNPs in
this work.
Zeta potential measurement and stability of PNPs
The dispersion of PNPs is easy to aggregate due to their
high specific surface areas (Figure 3). It was expected
that the storage stability of PNPs could be improved
after coating with SDS. To explore the reason about the
improved storage stability of metallic nanoparticles, theirout SDS.
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Figure 5 Results of MTT test on MCF-7 and HepG-2 under
various concentrations of PNPs. Results are expressed as a
percentage of viability compared to control and are presented as
mean ± SD from at least three independent experiments.
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ment gives an idea of the surface charge associated with
the particles. The particle charge is one of the factors in
determining the physical stability of emulsions and sus-
pensions. If all the particles in suspension have a large
negative or positive zeta potential, then they will tend to
repel each other and there is no tendency to flocculate.
However, if the particles have low zeta potential values,
then there is no force to prevent the particles from com-
ing together and to flocculate. The general dividing line
between stable and unstable suspensions is generally
taken at about either +30 or −30 mV. Particles with zeta
potentials more positive than +30 mV or more negative
than −30 mV are normally considered stable. As can be
seen from the SEM micrographs and zeta potentials,
there is stability on platinum particles obtained in this
work. When the particle size decreases, the absolute
value of zeta potential increases. The zeta potential of
PNPs was measured (Figure 4). The zeta potentials of
PNPs resulted in strong charge repulsive forces, which
prevented aggregation among PNPs.
Results of MTT assay
Different concentrations of PNPs 0, 1, 2, 4, and 8 mg/ml at
24 h have cytotoxicity effects on MCF-7 and HepG-2 cell
lines. Compared to the controls, different doses of PNPs
decreased the MCF-7 and HepG-2 cells, respectively:
for 1 mg/ml, 13.124% (difference not significant P > 0.05)
and 4.524% (difference not significant P > 0.05); for
2 mg/ml, 25.184% (difference not significant P > 0.05) and
34.97% (P < 0.001); for 4 mg/ml, 37.24% (difference not
significant P > 0.05) and 67.854% (P < 0.001); for 8 mg/ml,
53.5% (P < 0.05) and 91.8% (P < 0.001) (see Figure 5). TheIC50 of the PNPs after 24 h for MCF-7 and HepG-2 cell
lines was calculated as 6.8294 and 2.9044 mg/ml,
respectively (P < 0.05). There was a significant difference
between the PNP effect on growth depression of MCF-7
and HepG-2 cells (P < 0.05).
Conclusion
PNPs with a mean size of 34 nm were synthesized by a
salt reduction reaction having high stability. The major
advantage of using trisodium citrate as a reducing agent
is that an improved control over not only particle size
but also morphology distribution can be achieved
through the choice of the stabilizing agent. Aside from
Mohammadi et al. International Nano Letters 2013, 3:28 Page 5 of 5
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anticancer drugs. PNPs may display multiple functional
groups at the surface, which can be hydrophilic, lipo-
philic, and chemically reactive. Some of the platinum
compounds are used as very effective anticancer agents.
This property is associated with the inhibition of DNA
replication and mitosis by the addition of PNPs DNA
strand [25]. The purpose of this study is to assess the
biological assay of PNPs on cancerous cell lines. In 2010,
Porcel et al. showed that the addition of PNPs enhances
strongly the lethality of damage and, thus, the biological
efficiency of radiations [26]. The results demonstrated
concentration-dependent toxicity for the cells tested,
and CC50 was determined to be 2.904 and 6.829 mg/ml
in HepG-2 and MCF-7, respectively.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HM, AnA, and AzA carried out the designing, synthesizing, and characterizing
the nanoparticles. MJM and HES carried out the MTT assay. MRM, SJ, and MC
participated in the design of the study and performed the statistical analysis.
All authors read and approved the final manuscript.
Acknowledgments
The authors are grateful to the Department of Pilot Nano Biotechnology,
Pasteur Institute of Iran for the financial support for this research.
Author details
1Department of Chemistry, Islamic Azad University, North Tehran Branch,
Tehran, Iran. 2Department of Pilot Nanobiotechnology, Pasteur Institute of
Iran, Tehran, Iran. 3Department of Biology, Islamic Azad University, Zarghan
Branch, Zarghan, Iran. 4Department of Biochemistry, Pasteur Institute of Iran,
Tehran, Iran.
Received: 24 August 2011 Accepted: 8 October 2012
Published: 26 April 2013
References
1. Henglein, A: Small-particle research: physicochemical properties of
extremely small colloidal metal and semiconductor particles. Chem. Rev. 89,
1861 (1989)
2. Oggawa, S, Hayashi, Y, Kobayashi, N, Tokizakiand, T, Nakamura, A: Novel
preparation method of metal particles dispersed in polymer films and their
third-order optical nonlinearities. Jpn. J. Appl. Phys. 33, 331 (1994)
3. Chen, X, Schluesener, HJ: Nanosilver: a nanoproduct in medical application.
Toxicol. Lett. 4, 176 (2008)
4. Thomas, JM: Colloidal metals: past, present and future. Pure. Appl. Chem.
60, 1517 (1998)
5. Hirai, H, Toshima, N: Polymer-attached catalyst. In: Iwasawa, Y, Reidel, D. (eds.)
Tailored Metal Catalysts, 121st edn, pp. 121–140. Reidel, Dordrecht (1986)
6. Bönnemann, H, Brijoux, W, Brinkmann, R, Fretzen, R, Joussen, T, Köppler, R,
Korall, B, Neiteler, P, Richter, J: Preparation, characterization, and application
of fine metal particles and metal colloids using hydrotriorganoborates. J.
Mol. Catal. 86, 129 (1994)
7. dos Santos Júnior, HM, Oliveira, DF, de Carvalho, DA, Pinto, JM, Campos, VA,
Mourão, AR, Pessoa, C, de Moraes, MO, Costa-Lotufo, LV: Evaluation of native
and exotic Brazilian plants for anticancer activity. J. Nat. Med. 64, 231 (2010)
8. Decatris, MP, Sundar, S, O'Byrne, KJ: Platinum-based Chemotherapy in
Metastatic Breast Cancer: The Leicester (UK) Experience. Cancer. Treat. Rev.
30, 53 (2004)
9. Toshima, N, Wang, Y: Polymer-protected cu/pd bimetallic clusters. Adv.
Mater. 6, 245 (1994)
10. Toshima, N, Harada, M, Yonezawa, T, Kushihashiand, K, Asakura, K: Structural
analysis of polymer-protected palladium/platinum bimetallic clusters asdispersed catalysts by using extended x-ray absorption fine structure
spectroscopy. J. Phys. Chem. 95, 7448 (1991)
11. Bradley, JS, Hill, EW, Behal, S, Klein, C: Preparation and characterization of
organosols of monodispersed nanoscale palladium. Particle size effects in the
binding geometry of adsorbed carbon monoxide. Chem. Mater. 4, 1234 (1992)
12. Poulin, JC, Kagan, HB, Vargaftik, MN, StolarovandI, IP, Moiseev, II: Scanning
tunneling microscopy observation of giant palladium-561 clusters. J. Mol.
Catal. 95, 109 (1995)
13. Amiens, C, De Caro, D, Chaudret, B, Bradley, JS, Mazel, R, Roucau, C:
Selective synthesis, characterization, and spectroscopic studies on a novel
class of reduced platinum and palladium particles stabilized by carbonyl
and phosphine ligands. J. Am. Chem. Soc. 115, 11638 (1993)
14. Jiang, X, Xie, Y, Lu, J, Zhu, L, He, W, Qian, Y: Preparation, characterization,
and catalytic effect of CS2-stabilized silver nanoparticles in aqueous solution.
Langmuir 17, 3795 (2001)
15. Naka, K, Yaguchi, M, Chujo, Y: Synthesis of poly(oxyethylene)-grafted
palladium clusters. Chem. Mater. 11, 849 (1999)
16. Warner, MG, Reed, SM, Hutchison, JE: Small, water-soluble, ligand-stabilized
gold nanoparticles synthesized by interfacial ligand exchange reactions.
Chem. Mater. 12, 3316 (2000)
17. Mayer, A, Antonietti, M: Investigation of polymer-protected noble metal
nanoparticles by transmission electron microscopy: control of particle
morphology and shape. Colloid. Polym. Sci. 276, 769 (1998)
18. Zhou, Y, Yu, SH, Cui, XP, Wang, CY, Chen, ZY: Formation of silver nanowires
by a novel solid–liquid phase arc discharge method. Chem. Mater.
11, 545 (1999)
19. Yonezawa, T, Onoue, SY, Kimizuka, N: Formation of uniform fluorinated gold
nanoparticles and their highly ordered hexagonally packed monolayer.
Langmuir 17, 2291 (2001)
20. Ahmadi, TS, Wang, ZL, Green, TC, Hengleinand, A, El-Sayed, MA: Shape-
controlled synthesis of colloidal platinum nanoparticles. Science 272(5270),
1924–1925 (1996)
21. Soule, HD, Vazquez, J, Long, A, Albert, S, Brennan, M: A human cell line from
a pleural effusion derived from a breast carcinoma 2. J. Natl. Cancer. Inst. 51,
1409 (1973)
22. Levenson, AS, Jordan, VC: MCF-7: the first hormone-responsive breast
cancer cell line. Cancer. Res. 57, 3071 (1997)
23. Vidal-Iglesias, FJ, Solla-Gullon, J, Rodriquez, P, Herrero, E, Montiel, V, Feliu, JM,
Aldaz, A: Shape-dependent electrocatalysis: ammonia oxidation on platinum
nanoparticles with preferential (1 0 0) surfaces. Electrochem. Commun. 6,
1080 (2004)
24. Mokhtari, MJ, Motamed, N, Shokrgozar, MA: Evaluation of silibinin on the
viability, migration and adhesion of the human prostate adenocarcinoma
(PC-3) cell line. Cell. Biol. Int. 32, 888 (2008)
25. Sawosz, E, Chwalibog, A, Szeliga, J, Sawosz, F, Grodzik, M, Rupiewicz, M,
Niemiec, T, Kacprzyk, K: Visualization of gold and platinum nanoparticles
interacting with Salmonella enteritidis and Listeria monocytogenes. Int. J.
Nanomedicine. 7(2010), 631 (2010)
26. Porcel, E, Liehn, S, Remita, H, Usami, N, Kobayashi, K, Furusawa, Y, Le Sech, C,
Lacombe, S: Platinum nanoparticles: a promising material for future cancer
therapy? Nanotechnology 21, 085103 (2010)
doi:10.1186/2228-5326-3-28
Cite this article as: Mohammadi et al.: Evaluation of synthesized
platinum nanoparticles on the MCF-7 and HepG-2 cancer cell lines.
International Nano Letters 2013 3:28.
